Choosing Wisely guidelines can miss important findings, neurosurgeons argue.
New guidelines suggesting that imaging not be routinely performed on patients who complain about uncomplicated headaches were recommended in 2012 as part of the Choosing Wisely® campaign. The campaign is an initiative of the American Board of Internal Medicine (ABIM) Foundation. The new guidelines also proposed that neuroimaging only be recommended for patients with stable headaches who present with localized neurological signs or symptoms. The ABIM worked with a number of professional organizations, including the American College of Radiology (ACR), to provide evidence-based recommendations that would reduce the use of imaging among certain groups of patients.
The campaign produces promotional materials for patients, which describe the rationale behind the recommendations. The neuroimaging material explains that, for most headaches, a thorough medical history and neurological examination is all that is usually required for an accurate diagnosis. “Adding a CT scan or MRI rarely shows why a headache occurs or helps you manage its symptoms,” the document says. “And research shows that for people with a normal medical history and neurological exam, imaging tests are unlikely to reveal a more serious underlying problem.”
Some neurosurgeons are expressing concern over these new guidelines, fearing that some patients with brain tumors may slip through the cracks. A retrospective review of 95 patients with brain neoplasms showed that 24.2% of patients who had complained of an isolated headache, but did not have any symptoms or had non-specific symptoms, had brain tumors diagnosed by brain biopsy. The study was published in the journal Neurology.[[{"type":"media","view_mode":"media_crop","fid":"31592","attributes":{"alt":"Charles Park, MD","class":"media-image media-image-right","id":"media_crop_8282285278876","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3332","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 137px; width: 160px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"Charles Park, MD","typeof":"foaf:Image"}}]]
The researchers suggested that had the new Choosing Wisely guidelines been followed for these patients, some may not have been diagnosed with brain tumors as early as they were, thus delaying treatment.
There is a need for protocols within the healthcare system to reduce the rate of unnecessary examinations, physicians agree. However, there is not yet a consensus on how to do this. “I think it’s a good idea for them to get some kind of protocol for headaches and neuroimaging of the brain,” Charles Park, MD, a neurosurgeon with Central Maryland Neurosurgical Associates, said in an interview with Diagnostic Imaging. “But I also agree that limited access to neuroimaging may miss a lot of pathology.”
Of course, there are certain types of headaches that warrant imaging because they are characteristic of patients with brain tumors, according to Park, such as headaches that are present upon waking in the morning. “This is a big red flag and if someone has that, I think they need to have neuroimaging right away.”
According to Choosing Wisely informational literature, patients with headaches who are worried that there may be a serious problem are encouraged to ask for imaging if their headaches fall into any of these categories:
• Sudden or explosive
• Different from other headaches they have had in the past, especially if the patient is 50 years or older
• Brought on by exertion
• Accompanied by fever, seizure, vomiting, a loss of coordination, or a change in vision, speech, or alertness
Limiting the use of radiologic imaging has two goals: reducing patient exposure to unnecessary tests and reducing costs. When discussing the issue of cost savings from such a protocol, Park wasn’t convinced that the high costs seen in health care are necessarily because of neuroimaging. “I think these patients have far more costs associated with their treatments, medications, and physical therapy, rather than just from neuroimaging alone,” he explained. “I think they should image the brain as soon as possible, earlier than later, because once you know there is no pathology in the brain, physicians can offer other treatment modalities.”
Early neurologic imaging may seem like defensive medicine, but there is much to be said about providing patients with peace of mind too, Park continued. “From a patient’s perspective, it really changes things to know that there is no more uncertainty about whether you have a deadly disease, and I think that is worth a lot.”
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
CT Perfusion Study Shows Enhanced Detection of Medium Vessel Occlusions with Emerging AI Software
May 21st 2025The Rapid CTP AI software offered 23 percent greater detection of medium vessel occlusions in comparison to the Viz CTP AI software, according to research presented at the European Stroke (Organization) Conference (ESOC).
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.